Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,238 total articles
Palantir delivered a blowout Q2 (93% revenue growth) and guidance lift, and the stock is re-rating as investors rotate into software from chips. The business combines sticky government contracts with accelerating commercial AI wins — a combination that supports a premium multiple. This trade targets continued multiple expansion into $200+ territory…
TAT Technologies (TATT) looks to be stabilizing after a rocky first quarter. Solid Q2 2025 results, a $523M market cap, and improving MRO demand underpin our bullish trade idea. We outline an actionable entry at $39.50, a $34.50 stop, and a $55.00 target over a mid-term (45 trading days) horizon, with clear risk triggers and what would change our v…
<p>Roivant (ROIV) is trading within striking distance of its 52-week high while sitting on a balance sheet that looks more like a strategic toolkit than a simple war chest. The company reported roughly $4.4B in cash and effectively no debt, giving management real optionality to fund late-stage programs, pursue tuck-in acquisitions, or return capita…
Idexx (IDXX) is a high-quality diagnostics business with recurring revenue, industry-leading margins and accelerating diagnostic frequency. Recent results and raised guidance support continued top-line momentum. The stock trades at a premium, but fundamentals and cash generation make a disciplined long trade attractive over a 180 trading-day horizo…
B2Gold's fire at the Goose crushing circuit is a definable, contained hit to Q2 output but does not change the company's cash-generation profile or strategic progress. Use a disciplined, mid-term long trade that leans on de-risking from the Fingold sale, robust production last year and heavy intraday flows that can fuel a continuation move.
B2Gold just turned a string of operational and corporate catalysts into a clear trading opportunity. Fekola's steady output, a $325M divestiture, and resilient quarterly metrics have combined with heavy volume and bullish momentum to create an actionable mid-term long setup. Entry at $5.03, target $6.28, stop $4.00 — mid-term (45 trading days) plan…
Altria (MO) corrected sharply after a Q2 miss and volume headwinds, but the balance sheet, $9.1B in free cash flow, a ~6.2% yield and single-digit FCF valuation make this a tactical buy for a long-term trade horizon. This idea lays out entry, stop and target with catalysts and a balanced risk view.
Microsoft is trading near $500 after an extended run, but the core business - cloud, Office, LinkedIn and a growing AI platform - still generates predictable cash flow and profitable growth. At a market cap north of $3.7 trillion and free cash flow near $67B, Microsoft remains a buy-and-hold anchor with room to compound over the next 180 trading da…
Microsoft is benefiting from a clear rotation into software amid the 2026 AI wave. Fundamentals remain solid - $3.80T market cap, $66.99B free cash flow, and double-digit returns on equity - and technicals show strong momentum. This is a tactical long trade to capture the next leg higher, with a defined stop and target to manage the duration mismat…
Sterling Infrastructure (STRL) is a leader in building large-scale electrical and site systems for AI data centers, e-commerce warehouses and traditional transportation projects. The company is trading well below its highs after a sector-wide correction, but fundamentals remain strong: an e-infrastructure backlog above $5.1B, projected full-year re…
Wingstop has seen its share price collapse from cycle highs, but the underlying business - an asset-light, franchise-led model with strong FCF and a massive committed unit pipeline - still points to material upside. This trade idea lays out an actionable long with entry, stop and targets across a 45-to-180 trading-day horizon, plus catalysts and ba…
Allstate has completed a dramatic operational recovery: underwriting performance has improved, catastrophe losses are down, and investment yields are benefiting from a higher-rate environment. At $267.06 the stock trades cheaply on trailing multiples, but much of the easy upside from the turnaround is already priced in. This trade idea favors a dis…
Arm is transitioning from pure-play IP licensing toward a broader role powering agentic AI workloads through CPUs and platform-level offerings. Strong fiscal Q1 results, early AGI CPU demand, and a raised server TAM justify a mid-term long. Valuation is rich, so this trade uses defined entry, stop and target levels to manage risk while capturing up…
KeyCorp (KEY) offers a compelling risk-reward now: a ~4.3% yield, a fresh $3.0 billion buyback authorization and free cash flow of $2.18B support shareholder returns, while valuation sits at P/E ~13.5 and P/B ~1.22. We outline a structured long trade for the next 180 trading days with explicit entry, target and stop-loss levels and balanced risk fr…
Federal Agricultural Mortgage Corp (AGM) is trading on a clear fundamental and technical run: trailing EPS of $18.43, a P/E near 12.8, and a $1.60 quarterly common dividend combine with momentum indicators to argue for a mid-term long. Our trade plan targets a move to $255 with a stop at $224 and a mid-term horizon of 45 trading days.
Northrop Grumman's Q2 cadence and a reported $7.6B Sentinel-related surge sharpen program visibility for Space Systems and strategic deterrence work. With solid free cash flow, healthy returns, and bullish technicals, this trade aims to capture further re-rating over the next 45 trading days while protecting against program or macro setbacks.
Equity Bancshares (EQBK) is a small regional bank trading near $51 with a clear growth-through-acquisition strategy. Recent M&A and steady loan growth support a case for resuming outperformance; valuation is reasonable on a price-to-book of ~1.28 but P/E and EV/EBITDA are elevated. This trade idea outlines a long entry at $50.94 with a $60 target a…
Pacira (PCRX) is a sub-$1.0B market-cap specialty pharma with a recognizable non-opioid franchise (EXPAREL) and complementary assets. New real-world evidence showing large per-case cost savings, paired with improving reimbursement dynamics and a modest valuation (EV/EBITDA ~10.9; market cap ≈ $1.0B), create a tactical long opportunity. Trade plan: …
Praxis (PRAX) has shifted from clinical-stage story to commercial readiness. NDA acceptance for ulixacaltamide, blockbuster-like Phase signals on elsunersen, veteran commercial hires and heavy institutional demand create a path for outsized upside. This trade idea outlines an actionable long with entry, stop and target, and a 180-trading-day horizo…
SCZ (iShares MSCI EAFE Small-Cap ETF) offers broad exposure to Europe, Asia and the Far East small-cap complex at a reasonable valuation, a 3%+ distribution yield and bullish technicals. We prefer a mid-term long trade: entry $86.80, stop $83.00, target $92.00 over 45 trading days.
Mitek Systems (MITK) reported developments around Q3 that strengthen the bull case: improving operating momentum, partnerships expanding biometric capabilities, and a valuation that still leaves room for upside. This is a swing trade idea to capture re-rating into the mid-20s if momentum continues, with strict stop loss to limit downside.
Cresud (CRESY) remains priced like a beaten-up commodity play despite structural tailwinds from Argentina’s recent reform package and an asset base that should support a meaningful NAV rerating. This trade idea lays out a long-term (180 trading days) tactical long with defined entry, stop and target, plus the catalysts and risks that matter.
Copa Holdings' near-term volatility is likely driven by a noisy Q2 print and seasonal factors. Underneath, monthly traffic shows accelerating demand (April ASMs and RPMs +16.7% YoY) and a stable high load factor near 87%. At a $5.85B market cap with a P/E around 8.5 and a 4.55% yield, Copa looks undervalued for a capacity-constrained recovery in La…
Delcath Systems (DCTH) has traded up from its 2025 lows and is showing momentum indicators and improving fundamentals that suggest near-term headwinds are receding. With a market cap under $1 billion, positive free cash flow last reported, and heavy analyst upside expectations, a disciplined long trade captures a potential re-rating if commercial t…
dLocal is a cross-border payments rails specialist focused on emerging markets. Recent operational momentum (Q1 TPV > $14B, gross profit $119M) and Russell index inclusion are compelling catalysts. The stock trades at $14.41 with a $4.25B market cap and still looks attractive if take rates stabilize and TPV growth sustains. Trade plan: enter at $14…
